Jacobs Levy Equity Management, Inc Codiak Bio Sciences, Inc. Transaction History

Jacobs Levy Equity Management, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.0 - $16.78 $221,290 - $371,324	-22,129 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$15.58 - $22.88 $139,082 - $204,249	-8,927 Reduced 28.74%	22,129 $361,000
Q2 2021 Aug 16, 2021	SELL	$11.72 - $26.81 $993,891 - $2.27 Million	-84,803 Reduced 73.2%	31,056 $575,000
Q1 2021 May 17, 2021	BUY	$13.49 - $31.53 $1.26 Million - $2.96 Million	93,730 Added 423.56%	115,859 $1.75 Million
Q4 2020 Feb 16, 2021	BUY	$7.9 - $32.3 $174,819 - $714,766	22,129 New	22,129 $715,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.